Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Noninvasive measures of liver fibrosis.

Rockey DC, Bissell DM.

Hepatology. 2006 Feb;43(2 Suppl 1):S113-20. Review.

PMID:
16447288
2.
3.

Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.

Bedossa P.

Liver Int. 2009 Jan;29 Suppl 1:19-22. doi: 10.1111/j.1478-3231.2008.01940.x. Review.

PMID:
19207962
4.

Noninvasive monitoring of patients with chronic hepatitis C.

Fontana RJ, Lok AS.

Hepatology. 2002 Nov;36(5 Suppl 1):S57-64. Review.

5.

Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.

Denzer UW, Lüth S.

Best Pract Res Clin Gastroenterol. 2009;23(3):453-60. doi: 10.1016/j.bpg.2009.03.002. Review.

PMID:
19505671
6.

Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.

Verveer C, de Knegt RJ.

Scand J Gastroenterol Suppl. 2006;(243):85-8. Review.

PMID:
16782627
7.

[Clinical application of non-invasive diagnosis for hepatic fibrosis].

Cho SW, Cheong JY.

Korean J Hepatol. 2007 Jun;13(2):129-37. Review. Korean.

8.

Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?

Mardini H, Record C.

Ann Clin Biochem. 2005 Nov;42(Pt 6):441-7. Review.

PMID:
16259794
9.

Noninvasive biochemical markers of liver fibrosis.

Grigorescu M.

J Gastrointestin Liver Dis. 2006 Jun;15(2):149-59. Review.

10.

Assessing liver fibrosis.

Castera L.

Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):541-52. doi: 10.1586/17474124.2.4.541. Review.

PMID:
19072402
11.

Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.

Castera L.

J Viral Hepat. 2009 May;16(5):300-14. doi: 10.1111/j.1365-2893.2009.01087.x. Epub 2009 Feb 25. Review.

PMID:
19254351
12.

Assessment of fibrosis in chronic liver diseases.

Zhou K, Lu LG.

J Dig Dis. 2009 Feb;10(1):7-14. doi: 10.1111/j.1751-2980.2008.00356.x. Review.

PMID:
19236541
13.

Noninvasive tests for liver fibrosis.

Luxon BA.

Postgrad Med. 2006 Sep-Oct;119(3):8-13. Review.

PMID:
17128639
14.

Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease.

Castera L.

Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):291-303. doi: 10.1016/j.bpg.2011.02.003. Review.

PMID:
21497746
15.

Diagnosis and quantitation of fibrosis.

Manning DS, Afdhal NH.

Gastroenterology. 2008 May;134(6):1670-81. doi: 10.1053/j.gastro.2008.03.001. Review.

PMID:
18471546
16.

Non-invasive markers of liver fibrosis in HCV mono-infected and in HIV/HCV co-infected subjects.

Bongiovanni M, Casana M.

Med Chem. 2008 Nov;4(6):513-19. Review.

PMID:
18991734
17.

Non-invasive assessment of chronic liver and gastric diseases.

Plebani M, Basso D.

Clin Chim Acta. 2007 May;381(1):39-49. Epub 2007 Feb 20. Review.

PMID:
17374528
18.

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.

Wieckowska A, McCullough AJ, Feldstein AE.

Hepatology. 2007 Aug;46(2):582-9. Review.

PMID:
17661414
19.

[Hepatic fibrosis: physiopathology and biological diagnosis].

Housset C, Guéchot J.

Pathol Biol (Paris). 1999 Nov;47(9):886-94. Review. French.

PMID:
10609268
20.

Circulating markers of liver fibrosis progression.

Jarcuska P, Janicko M, Veselíny E, Jarcuska P, Skladaný L.

Clin Chim Acta. 2010 Aug 5;411(15-16):1009-17. doi: 10.1016/j.cca.2010.04.009. Epub 2010 Apr 23. Review.

PMID:
20399764

Supplemental Content

Support Center